ArticleCell communication and signaling : CCS2023

Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.

Atefeh Khodakarami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.